Case Study

Understand the regulatory environment, treatment pathways and patient journey for rare diseases in targeted geographies

Understand the regulatory environment, treatment pathways and patient journey for rare diseases in targeted geographies

Pages 1 Pages

A biopharma preparing to commercialize a neurology rare disease asset in APAC engaged IQVIA for a pre-launch study. Through interviews with KOLs, patients, and payers, IQVIA mapped regulatory frameworks, treatment pathways, funding structures, and patient journeys. Insights highlighted disease burden, unmet needs, and ecosystem gaps, enabling the company to design an optimized go-to-market model. Results supported launch success by guiding product differentiation, stakeholder engagement, patient access, and identification of new opportunities to improve patient and payer experiences.

Join for free to read